NKp46-expressing human gut-resident intraepithelial Vδ1 T cell subpopulation exhibits high antitumor activity against colorectal cancer
Standard
NKp46-expressing human gut-resident intraepithelial Vδ1 T cell subpopulation exhibits high antitumor activity against colorectal cancer. / Mikulak, Joanna; Oriolo, Ferdinando; Bruni, Elena; Roberto, Alessandra; Colombo, Federico S; Villa, Anna; Bosticardo, Marita; Bortolomai, Ileana; Lo Presti, Elena; Meraviglia, Serena; Dieli, Francesco; Vetrano, Stefania; Danese, Silvio; Della Bella, Silvia; Carvello, Michele M; Sacchi, Matteo; Cugini, Giovanni; Colombo, Giovanni; Klinger, Marco; Spaggiari, Paola; Roncalli, Massimo; Prinz, Immo; Ravens, Sarina; di Lorenzo, Biagio; Marcenaro, Emanuela; Silva-Santos, Bruno; Spinelli, Antonino; Mavilio, Domenico.
In: JCI INSIGHT, Vol. 4, No. 24, 19.12.2019.Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review
Harvard
APA
Vancouver
Bibtex
}
RIS
TY - JOUR
T1 - NKp46-expressing human gut-resident intraepithelial Vδ1 T cell subpopulation exhibits high antitumor activity against colorectal cancer
AU - Mikulak, Joanna
AU - Oriolo, Ferdinando
AU - Bruni, Elena
AU - Roberto, Alessandra
AU - Colombo, Federico S
AU - Villa, Anna
AU - Bosticardo, Marita
AU - Bortolomai, Ileana
AU - Lo Presti, Elena
AU - Meraviglia, Serena
AU - Dieli, Francesco
AU - Vetrano, Stefania
AU - Danese, Silvio
AU - Della Bella, Silvia
AU - Carvello, Michele M
AU - Sacchi, Matteo
AU - Cugini, Giovanni
AU - Colombo, Giovanni
AU - Klinger, Marco
AU - Spaggiari, Paola
AU - Roncalli, Massimo
AU - Prinz, Immo
AU - Ravens, Sarina
AU - di Lorenzo, Biagio
AU - Marcenaro, Emanuela
AU - Silva-Santos, Bruno
AU - Spinelli, Antonino
AU - Mavilio, Domenico
PY - 2019/12/19
Y1 - 2019/12/19
N2 - γδ T cells account for a large fraction of human intestinal intraepithelial lymphocytes (IELs) endowed with potent antitumor activities. However, little is known about their origin, phenotype, and clinical relevance in colorectal cancer (CRC). To determine γδ IEL gut specificity, homing, and functions, γδ T cells were purified from human healthy blood, lymph nodes, liver, skin, and intestine, either disease-free, affected by CRC, or generated from thymic precursors. The constitutive expression of NKp46 specifically identifies a subset of cytotoxic Vδ1 T cells representing the largest fraction of gut-resident IELs. The ontogeny and gut-tropism of NKp46+/Vδ1 IELs depends both on distinctive features of Vδ1 thymic precursors and gut-environmental factors. Either the constitutive presence of NKp46 on tissue-resident Vδ1 intestinal IELs or its induced expression on IL-2/IL-15-activated Vδ1 thymocytes are associated with antitumor functions. Higher frequencies of NKp46+/Vδ1 IELs in tumor-free specimens from CRC patients correlate with a lower risk of developing metastatic III/IV disease stages. Additionally, our in vitro settings reproducing CRC tumor microenvironment inhibited the expansion of NKp46+/Vδ1 cells from activated thymic precursors. These results parallel the very low frequencies of NKp46+/Vδ1 IELs able to infiltrate CRC, thus providing insights to either follow-up cancer progression or to develop adoptive cellular therapies.
AB - γδ T cells account for a large fraction of human intestinal intraepithelial lymphocytes (IELs) endowed with potent antitumor activities. However, little is known about their origin, phenotype, and clinical relevance in colorectal cancer (CRC). To determine γδ IEL gut specificity, homing, and functions, γδ T cells were purified from human healthy blood, lymph nodes, liver, skin, and intestine, either disease-free, affected by CRC, or generated from thymic precursors. The constitutive expression of NKp46 specifically identifies a subset of cytotoxic Vδ1 T cells representing the largest fraction of gut-resident IELs. The ontogeny and gut-tropism of NKp46+/Vδ1 IELs depends both on distinctive features of Vδ1 thymic precursors and gut-environmental factors. Either the constitutive presence of NKp46 on tissue-resident Vδ1 intestinal IELs or its induced expression on IL-2/IL-15-activated Vδ1 thymocytes are associated with antitumor functions. Higher frequencies of NKp46+/Vδ1 IELs in tumor-free specimens from CRC patients correlate with a lower risk of developing metastatic III/IV disease stages. Additionally, our in vitro settings reproducing CRC tumor microenvironment inhibited the expansion of NKp46+/Vδ1 cells from activated thymic precursors. These results parallel the very low frequencies of NKp46+/Vδ1 IELs able to infiltrate CRC, thus providing insights to either follow-up cancer progression or to develop adoptive cellular therapies.
KW - Adult
KW - Age Factors
KW - Aged
KW - Aged, 80 and over
KW - Animals
KW - Antigens, Ly/metabolism
KW - Colon/cytology
KW - Colorectal Neoplasms/immunology
KW - Disease Progression
KW - Female
KW - Humans
KW - Ileum/cytology
KW - Immunotherapy, Adoptive/methods
KW - Intestinal Mucosa/cytology
KW - Intraepithelial Lymphocytes/immunology
KW - Male
KW - Mice
KW - Middle Aged
KW - Natural Cytotoxicity Triggering Receptor 1/metabolism
KW - Neoplasm Staging
KW - Receptors, Antigen, T-Cell, gamma-delta/metabolism
KW - Sex Hormone-Binding Globulin
KW - T-Lymphocytes, Cytotoxic/immunology
KW - Young Adult
U2 - 10.1172/jci.insight.125884
DO - 10.1172/jci.insight.125884
M3 - SCORING: Journal article
C2 - 31689241
VL - 4
JO - JCI INSIGHT
JF - JCI INSIGHT
SN - 2379-3708
IS - 24
ER -